Data / Form D filings / Protogenix Inc.
Protogenix Inc.: Form D filing
Protogenix Inc., a biotechnology company in Ithaca, NY, filed a Form D with the SEC in 2026. The latest, on February 13, 2026, reports $250,000 sold of a $4.2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 237 TOWER RD WEILL HALL 409, Ithaca, NY, 14853
- Phone
- (607) 592-8781
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2110349
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | New notice | $4,200,000 | $250,000 | $3,950,000 | 1 | Dec 24, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher PJ Wightman | Executive Officer, Director | |
| Eric R Pettee | Executive Officer, Director | |
| Robert Poltrino | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Feb 9, 2026 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Protogenix Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.